
AODT-0004
Retatrutide
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
- CAS
- 2381609-36-3
- Purity
- ≥99.05%
- Grade
- Research
Priority Sales Hotline
Tap to chat with us

AODT-0004
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
We use cookies
We use essential cookies to make our site work, and optional analytics & preference cookies to improve your experience. See our Cookie Policy.